Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Akira Tangoku

Showing results (141-150 of 174) with videos related to

Pageof 18
Sort By:
Respirology (Carlton, Vic.)|February 22, 2021
Cone-beam computed tomography versus computed tomography-guided ultrathin bronchoscopic diagnosis for peripheral pulmonary lesions: A propensity score-matched analysisNaoya Kawakita, Hiromitsu Takizawa, Hiroaki Toba, et al.
International Journal of Oncology|November 21, 2019
DNA methylation of GHSR, GNG4, HOXD9 and SALL3 is a common epigenetic alteration in thymic carcinomaReina Kishibuchi, Kazuya Kondo, Shiho Soejima, et al.
Anticancer Research|July 9, 2011
Expression of p53, Ki-67, E-cadherin, N-cadherin and TOP2A in triple-negative breast cancerMisako Nakagawa, Yoshimi Bando, Taeko Nagao, et al.
Oncology Letters|May 10, 2021
GAD1 expression and its methylation as indicators of malignant behavior in thymic epithelial tumorsShiho Soejima, Kazuya Kondo, Mitsuhiro Tsuboi, et al.
International Journal of Oncology|March 8, 2018
Frequent downregulation of LRRC26 by epigenetic alterations is involved in the malignant progression of triple-negative breast cancerYoshimasa Miyagawa, Yosuke Matsushita, Hiromu Suzuki, et al.
Oncology Letters|October 11, 2021
<i>GHSR</i> methylation-dependent expression of a variant ligand and receptor of the ghrelin system induces thymoma tumorigenesisBilguun Tegshee, Kazuya Kondo, Shiho Soejima, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 14, 2003
Prediction of nodal metastasis by comparative genomic hybridization in biopsy specimens from patients with superficial esophageal squamous cell carcinomaTakashi Ueno, Akira Tangoku, Shigefumi Yoshino, et al.
International Journal of Clinical Oncology|March 5, 2020
Use of a prognostic risk score that aggregates the FDG-PET/CT SUVmax, tumor size, and histologic group for predicting the prognosis of pStage I lung adenocarcinomaNaoya Kawakita, Hiroaki Toba, Yukikiyo Kawakami, et al.
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|August 6, 2013
Monitoring of exhaled carbon monoxide and carbon dioxide during lung cancer operationNarmisheekh Khasag, Shoji Sakiyama, Hiroaki Toba, et al.
Cancer Chemotherapy and Pharmacology|September 11, 2019
Prophylactic administration of granulocyte colony-stimulating factor in epirubicin and cyclophosphamide chemotherapy for Japanese breast cancer patients: a retrospective studyTakumi Sakurada, Sanako Bando, Yoshito Zamami, et al.
Pageof 18

Showing results (141-150 of 174) with videos related to

Sort By:
Pageof 18
Respirology (Carlton, Vic.)|February 22, 2021
Cone-beam computed tomography versus computed tomography-guided ultrathin bronchoscopic diagnosis for peripheral pulmonary lesions: A propensity score-matched analysisNaoya Kawakita, Hiromitsu Takizawa, Hiroaki Toba, et al.
International Journal of Oncology|November 21, 2019
DNA methylation of GHSR, GNG4, HOXD9 and SALL3 is a common epigenetic alteration in thymic carcinomaReina Kishibuchi, Kazuya Kondo, Shiho Soejima, et al.
Anticancer Research|July 9, 2011
Expression of p53, Ki-67, E-cadherin, N-cadherin and TOP2A in triple-negative breast cancerMisako Nakagawa, Yoshimi Bando, Taeko Nagao, et al.
Oncology Letters|May 10, 2021
GAD1 expression and its methylation as indicators of malignant behavior in thymic epithelial tumorsShiho Soejima, Kazuya Kondo, Mitsuhiro Tsuboi, et al.
International Journal of Oncology|March 8, 2018
Frequent downregulation of LRRC26 by epigenetic alterations is involved in the malignant progression of triple-negative breast cancerYoshimasa Miyagawa, Yosuke Matsushita, Hiromu Suzuki, et al.
Oncology Letters|October 11, 2021
<i>GHSR</i> methylation-dependent expression of a variant ligand and receptor of the ghrelin system induces thymoma tumorigenesisBilguun Tegshee, Kazuya Kondo, Shiho Soejima, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 14, 2003
Prediction of nodal metastasis by comparative genomic hybridization in biopsy specimens from patients with superficial esophageal squamous cell carcinomaTakashi Ueno, Akira Tangoku, Shigefumi Yoshino, et al.
International Journal of Clinical Oncology|March 5, 2020
Use of a prognostic risk score that aggregates the FDG-PET/CT SUVmax, tumor size, and histologic group for predicting the prognosis of pStage I lung adenocarcinomaNaoya Kawakita, Hiroaki Toba, Yukikiyo Kawakami, et al.
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|August 6, 2013
Monitoring of exhaled carbon monoxide and carbon dioxide during lung cancer operationNarmisheekh Khasag, Shoji Sakiyama, Hiroaki Toba, et al.
Cancer Chemotherapy and Pharmacology|September 11, 2019
Prophylactic administration of granulocyte colony-stimulating factor in epirubicin and cyclophosphamide chemotherapy for Japanese breast cancer patients: a retrospective studyTakumi Sakurada, Sanako Bando, Yoshito Zamami, et al.
Pageof 18